Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apollo Hospitals EnterpriseBOM:508869 -0.85%92 PE Ratio without NRI is 64.74 as of Jul. 25, 2026, which is 18% below its 10-year median of 78.80. GuruFocus rates BOM:508869 with a GF Score™ of 92/100 and a GF Value™ of ₹8,817.38 (Fairly Valued). The stock has 4 warning signs investors should review. Among 438 Healthcare Providers & Services companies, Apollo Hospitals Enterprise ranks worse than 86.07% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-25), Apollo Hospitals Enterprise's share price is ₹8804.30.
Apollo Hospitals Enterprise's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹136.00. Therefore, Apollo Hospitals Enterprise's PE Ratio without NRI for today is 64.74.
During the past 13 years, Apollo Hospitals Enterprise's highest PE Ratio without NRI was 666.33. The lowest was 51.44. And the median was 78.80.
Apollo Hospitals Enterprise (BOM:508869) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
Apollo Hospitals Enterprise PE Ratio without NRI Related Terms
Apollo Hospitals Enterprise PE Ratio without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise PE Ratio without NRI Chart
BOM:508869 vs HCA, THC, DVA: PE Ratio without NRI Comparison
For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apollo Hospitals Enterprise PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Apollo Hospitals Enterprise's PE Ratio without NRI falls into.
Apollo Hospitals Enterprise PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
Apollo Hospitals Enterprise's Share Price of today is ₹8804.30.
Apollo Hospitals Enterprise's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹136.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Apollo Hospitals Enterprise (BOM:508869) has a PE Ratio without NRI of 64.74 as of Jul. 25, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Apollo Hospitals Enterprise and its competitors. This is 18% below median its historical median of 78.80. Over the past decade, Apollo Hospitals Enterprise's PE Ratio without NRI has ranged from 51.44 to 666.33. According to the industry distribution chart, Apollo Hospitals Enterprise ranks #377 out of 438 companies in the Healthcare Providers & Services industry, placing it in the top 86.1%.
Is Apollo Hospitals Enterprise's PE Ratio without NRI too high?
Apollo Hospitals Enterprise's current PE Ratio without NRI of 64.74 is 18% below median its 10-year median of 78.80. Over the past 10 years, this metric has ranged from a low of 51.44 to a high of 666.33. The Healthcare Providers & Services industry median PE Ratio without NRI is 19.65. Apollo Hospitals Enterprise's value of 64.74 is 229.5% above this industry median. Based on the distribution chart, Apollo Hospitals Enterprise ranks #377 out of 438 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Apollo Hospitals Enterprise has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's PE Ratio without NRI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Apollo Hospitals Enterprise ranks #377 out of 438 companies for PE Ratio without NRI. This places Apollo Hospitals Enterprise in the lower half of its industry. The industry median PE Ratio without NRI is 19.65. Apollo Hospitals Enterprise's value of 64.74 is 229.5% above this benchmark. Historically, Apollo Hospitals Enterprise's own PE Ratio without NRI has ranged from 51.44 to 666.33 over the past decade. While the company's 10-year median is 78.80 vs. the industry median of 19.65, Apollo Hospitals Enterprise has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 19.65, based on 438 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current PE Ratio without NRI of 64.74 is 229.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Apollo Hospitals Enterprise and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 19.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current PE Ratio without NRI is 64.74, which is 18% below median its own 10-year median of 78.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,817.38, compared to a current price of ₹8,804.30 — trading 0.1% below its estimated fair value. The current PE Ratio without NRI is 64.74, which is 18% below median its 10-year median of 78.80 and 229.5% above the Healthcare Providers & Services industry median of 19.65. Apollo Hospitals Enterprise's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current PE Ratio without NRI is 64.74 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued.
The current stock price of ₹8,804.30 is trading 0.1% below its estimated GF Value™ of ₹8,817.38.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
PE Ratio without NRI: 64.74 (18% below median its 10-year median of 78.80)
GF Value™: ₹8,817.38 vs. price of ₹8,804.30 (0.1% below fair value)
Industry Position: 229.5% above the Healthcare Providers & Services median (#377 of 438)
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
92GF Score
Get the complete analysis for BOM:508869
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
